<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> may be a risk factor for <z:hpo ids='HP_0000726'>dementia</z:hpo>, but the associated pathological mechanisms remains unclear </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the association of <z:mp ids='MP_0002055'>diabetes</z:mp> alone or combined with the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (APOE) gene with incident <z:hpo ids='HP_0000726'>dementia</z:hpo> and neuropathological outcomes in a population-based cohort of 2,574 Japanese-American men enrolled in the Honolulu-Asia Aging Study, including 216 subjects who underwent autopsy </plain></SENT>
<SENT sid="2" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was ascertained by interview and direct <z:chebi fb="105" ids="17234">glucose</z:chebi> testing </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000726'>Dementia</z:hpo> was assessed in 1991 and 1994 by clinical examination and magnetic resonance imaging and was diagnosed according to international guidelines </plain></SENT>
<SENT sid="4" pm="."><plain>Logistic regression was used to assess the RR of developing <z:hpo ids='HP_0000726'>dementia</z:hpo>, and log-linear regression was used to estimate the incident rate ratio (IRR) of neuropathological outcomes </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> was associated with total <z:hpo ids='HP_0000726'>dementia</z:hpo> (RR 1.5 [95% CI 1.01-2.2]), <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD; 1.8 [1.1-2.9]), and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VsD; 2.3 [1.1-5.0]) </plain></SENT>
<SENT sid="6" pm="."><plain>Individuals with both type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the APOE epsilon4 allele had an RR of 5.5 (CI 2.2-13.7) for AD compared with those with neither risk factor </plain></SENT>
<SENT sid="7" pm="."><plain>Participants with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the epsilon4 allele had a higher number of hippocampal <z:hpo ids='HP_0100256'>neuritic plaques</z:hpo> (IRR 3.0 [CI 1.2-7.3]) and <z:hpo ids='HP_0002185'>neurofibrillary tangles</z:hpo> in the cortex (IRR 3.5 [1.6-7.5]) and hippocampus (IRR 2.5 [1.5-3.7]), and they had a higher risk of <z:hpo ids='HP_0011970'>cerebral amyloid angiopathy</z:hpo> (RR 6.6, 1.5-29.6) </plain></SENT>
<SENT sid="8" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is a risk factor for AD and VsD </plain></SENT>
<SENT sid="9" pm="."><plain>The association between <z:mp ids='MP_0002055'>diabetes</z:mp> and AD is particularly strong among carriers of the APOE epsilon4 allele </plain></SENT>
<SENT sid="10" pm="."><plain>The neuropathological data are consistent with the clinical results </plain></SENT>
</text></document>